O'Neill Gilmore Neil sold EDIT
September 3, 2025 · Form 4 insider transaction
O'Neill Gilmore Neil sold 5,592 shares of Editas Medicine, Inc. at $2.60 per share, a transaction worth $14.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
5,592
Price
$2.60
Total value
$14.5K
InsiderO'Neill Gilmore Neil
Role—
CompanyEditas Medicine, Inc. (EDIT)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 3, 2025
Filing dateSeptember 4, 2025
Shares owned after274,690
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.